HSBC HOLDINGS PLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 206 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$958,464
-15.5%
26,975
+10.9%
0.00%0.0%
Q2 2023$1,133,962
+4.8%
24,313
-10.0%
0.00%0.0%
Q1 2023$1,082,172
-67.0%
27,012
-62.7%
0.00%
-75.0%
Q4 2022$3,277,891
+617.3%
72,480
+568.1%
0.00%
+300.0%
Q3 2022$457,000
-43.6%
10,849
-21.0%
0.00%0.0%
Q2 2022$810,000
-24.2%
13,733
-6.4%
0.00%0.0%
Q1 2022$1,069,000
+95.4%
14,668
+127.9%
0.00%0.0%
Q4 2021$547,000
-10.5%
6,437
-5.8%
0.00%0.0%
Q3 2021$611,000
-26.7%
6,834
-21.2%
0.00%0.0%
Q2 2021$833,000
+73.5%
8,672
+106.0%
0.00%0.0%
Q1 2021$480,000
-65.6%
4,209
-57.7%
0.00%
-50.0%
Q4 2020$1,397,000
+213.9%
9,962
+89.3%
0.00%
+100.0%
Q3 2020$445,000
-59.6%
5,263
-79.3%
0.00%
-50.0%
Q4 2019$1,102,000
-9.4%
25,424
-10.6%
0.00%0.0%
Q3 2019$1,217,000
+471.4%
28,448
+582.7%
0.00%
Q1 2018$213,000
-64.9%
4,167
-51.8%
0.00%
-100.0%
Q4 2016$607,000
+177.2%
8,645
+303.8%
0.00%
Q2 2015$219,0002,1410.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2020
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders